Matches in Wikidata for { <http://www.wikidata.org/entity/Q37623972> ?p ?o ?g. }
- Q37623972 description "article científic" @default.
- Q37623972 description "article scientifique" @default.
- Q37623972 description "articolo scientifico" @default.
- Q37623972 description "artigo científico" @default.
- Q37623972 description "artículu científicu espublizáu en 2017" @default.
- Q37623972 description "bilimsel makale" @default.
- Q37623972 description "scientific article published on 27 January 2017" @default.
- Q37623972 description "vedecký článok" @default.
- Q37623972 description "vetenskaplig artikel" @default.
- Q37623972 description "videnskabelig artikel" @default.
- Q37623972 description "vědecký článek" @default.
- Q37623972 description "wetenschappelijk artikel" @default.
- Q37623972 description "wissenschaftlicher Artikel" @default.
- Q37623972 description "наукова стаття, опублікована в січні 2017" @default.
- Q37623972 description "научни чланак" @default.
- Q37623972 description "مقالة علمية نشرت في 27 يناير 2017" @default.
- Q37623972 name "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 name "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 name "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 type Item @default.
- Q37623972 label "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 label "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 label "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 prefLabel "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 prefLabel "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 prefLabel "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 P1433 Q37623972-1DEE613E-7343-425B-9327-0C3CB9422A82 @default.
- Q37623972 P1476 Q37623972-406ADF5B-0D02-45A5-BD85-15EAC61F99DF @default.
- Q37623972 P2093 Q37623972-0F2747F4-5AB5-491C-9965-E5673D72D07C @default.
- Q37623972 P2093 Q37623972-1DC6D2E2-1669-4ED0-9F37-663FD3F6B5D1 @default.
- Q37623972 P2093 Q37623972-2467B06C-24EF-4DFA-B036-F728FEE96DAD @default.
- Q37623972 P2093 Q37623972-913C06AB-36BF-46E9-A8B4-E46E4E2256AB @default.
- Q37623972 P2093 Q37623972-B52C7CE3-0F9E-43E4-A2EE-E967684C1597 @default.
- Q37623972 P275 Q37623972-e514464d-9e9a-4d2c-a906-ae1da054c6e6 @default.
- Q37623972 P2860 Q37623972-0A48DF8F-3843-45AA-9DA2-9D9F83ECFC71 @default.
- Q37623972 P2860 Q37623972-1482E009-F4D3-4CD7-9895-B2911DC3EDF4 @default.
- Q37623972 P2860 Q37623972-289C2B52-24ED-4089-8DCF-688DDF5A408C @default.
- Q37623972 P2860 Q37623972-2DB05BE5-183B-4518-A90A-16FD37A96720 @default.
- Q37623972 P2860 Q37623972-396A95F4-615B-4AE0-846D-16CD39A4F0A7 @default.
- Q37623972 P2860 Q37623972-3ED715B6-772D-4EB6-806B-84714A8DECFB @default.
- Q37623972 P2860 Q37623972-3F1F7FC2-165D-44CE-BF72-D2F865C70C44 @default.
- Q37623972 P2860 Q37623972-3FBF3946-6402-40FD-A9CF-97CEDD406842 @default.
- Q37623972 P2860 Q37623972-443E8CB7-3F4D-4846-A946-C88D60143824 @default.
- Q37623972 P2860 Q37623972-46A85347-5D43-4F99-9EBB-8E5C7F14B4B0 @default.
- Q37623972 P2860 Q37623972-5A4F659D-C0E3-4377-B573-5702AB2E2CD1 @default.
- Q37623972 P2860 Q37623972-675CADFB-1613-4BC5-A274-05F5019E529A @default.
- Q37623972 P2860 Q37623972-6862EF5D-759A-41FC-AB93-9179A4A26078 @default.
- Q37623972 P2860 Q37623972-6999ABDE-EE85-428B-9C61-C5F6F3A5CD9E @default.
- Q37623972 P2860 Q37623972-77A1D2DF-4E6E-4108-901F-789368E528E9 @default.
- Q37623972 P2860 Q37623972-79F9A0ED-BF26-4733-A0CF-B3D6EADB9FB2 @default.
- Q37623972 P2860 Q37623972-7F5A291E-DFA3-43E6-BF6D-031330EE3AC7 @default.
- Q37623972 P2860 Q37623972-854B9605-E665-45D8-8071-86C57732BEA0 @default.
- Q37623972 P2860 Q37623972-85AA0EBF-916C-4FEB-8C99-03DCF189E4A5 @default.
- Q37623972 P2860 Q37623972-8D258A0C-C52A-48C2-B545-55B657DCD7D6 @default.
- Q37623972 P2860 Q37623972-90DBE803-9CF7-4575-B1B1-F13540EFEF0B @default.
- Q37623972 P2860 Q37623972-95686135-4446-4478-B00D-6EFAAE7FDC58 @default.
- Q37623972 P2860 Q37623972-B46BEFBB-3E16-4B77-8EDE-33E4B9C79651 @default.
- Q37623972 P2860 Q37623972-B6B4BDAF-1E5C-4896-B139-60BBFE5BFF75 @default.
- Q37623972 P2860 Q37623972-C10BDC32-26DE-4DE1-937F-886A5356FEF9 @default.
- Q37623972 P2860 Q37623972-C245784B-5358-4B55-B234-9753F0DFA6B4 @default.
- Q37623972 P2860 Q37623972-C4947664-5204-49CE-B193-1126B3FDCC4A @default.
- Q37623972 P2860 Q37623972-C59AEF0A-45DB-45C3-A802-9D68249501A3 @default.
- Q37623972 P2860 Q37623972-CF603092-5D80-475C-B906-0BAE034106EB @default.
- Q37623972 P2860 Q37623972-D02A162A-CC41-4499-8A07-D0CB7C8A9D1D @default.
- Q37623972 P2860 Q37623972-D12445FB-A5F8-4B49-9B7A-31717C55122F @default.
- Q37623972 P2860 Q37623972-D1C12464-AABE-4C27-832F-F9063A27786B @default.
- Q37623972 P2860 Q37623972-E48FFF0B-FB43-4DA2-89A8-A0A6B99A87FA @default.
- Q37623972 P2860 Q37623972-E59646D0-53CA-4354-AC27-F19192D6DF87 @default.
- Q37623972 P2860 Q37623972-E5A0C8C4-C7C4-466D-88D9-0AD1406CD4C0 @default.
- Q37623972 P2860 Q37623972-F98E5A4D-61F0-45DC-A212-9D2C5713D6A9 @default.
- Q37623972 P304 Q37623972-B85868B0-F979-4091-BC64-189D7833E063 @default.
- Q37623972 P31 Q37623972-02AB6998-ECD1-4DB6-88DE-626B729B316B @default.
- Q37623972 P356 Q37623972-6EDCEEAC-852F-466F-9472-D158C5564E34 @default.
- Q37623972 P478 Q37623972-921C1EE6-52AE-4B22-81AA-49F7B56C9144 @default.
- Q37623972 P577 Q37623972-F2D54F5F-29FA-4CF5-9255-9FABAE32246C @default.
- Q37623972 P6216 Q37623972-e152d43b-c69c-4d06-95ca-4ff58bdec92e @default.
- Q37623972 P698 Q37623972-B1543226-C33A-4704-9A57-B9C972C99122 @default.
- Q37623972 P921 Q37623972-0B469177-44C9-4846-AAC5-D8DE5AB57510 @default.
- Q37623972 P921 Q37623972-CF41F847-007B-4753-94FF-6FCC3A4EFC63 @default.
- Q37623972 P932 Q37623972-FEB49F0D-50ED-4BB8-BC9E-9B3E2F949269 @default.
- Q37623972 P356 DMSO.S126291 @default.
- Q37623972 P698 28184166 @default.
- Q37623972 P1433 Q5270108 @default.
- Q37623972 P1476 "Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome" @default.
- Q37623972 P2093 "Dainius A Balis" @default.
- Q37623972 P2093 "Katherine W Merton" @default.
- Q37623972 P2093 "Mehul Desai" @default.
- Q37623972 P2093 "Michael J Davies" @default.
- Q37623972 P2093 "Ujjwala Vijapurkar" @default.
- Q37623972 P275 Q18810331 @default.
- Q37623972 P2860 Q21256400 @default.
- Q37623972 P2860 Q28254549 @default.
- Q37623972 P2860 Q29616309 @default.
- Q37623972 P2860 Q33613143 @default.
- Q37623972 P2860 Q34543009 @default.
- Q37623972 P2860 Q34646948 @default.
- Q37623972 P2860 Q34673134 @default.
- Q37623972 P2860 Q34804900 @default.
- Q37623972 P2860 Q36073442 @default.
- Q37623972 P2860 Q36762696 @default.